{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:08:34Z","timestamp":1780045714258,"version":"3.53.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.humpath.2026.106120","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T06:08:23Z","timestamp":1776233303000},"page":"106120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Osteosarcomas with H3F3A mutation a clinicopathological and molecular genetic study of 7 cases with review of the literature"],"prefix":"10.1016","volume":"173","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5037-0170","authenticated-orcid":false,"given":"Qingzhu","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2026.106120_bib1","series-title":"WHO classification of tumours soft tissue and bone tumours","year":"2020"},{"issue":"2","key":"10.1016\/j.humpath.2026.106120_bib2","first-page":"139","article-title":"Giant cell tumor of bone: an update, including spectrum of pathological features, pathogenesis, molecular profile and the differential diagnoses","volume":"38","author":"Rekhi","year":"2023","journal-title":"Histol Histopathol"},{"issue":"3","key":"10.1016\/j.humpath.2026.106120_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/PAP.0000000000000293","article-title":"The 2020 WHO classification of tumors of bone: an updated review","volume":"28","author":"Choi","year":"2021","journal-title":"Adv Anat Pathol"},{"issue":"12","key":"10.1016\/j.humpath.2026.106120_bib4","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/ng.2814","article-title":"Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone","volume":"45","author":"Behjati","year":"2013","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.humpath.2026.106120_bib5","first-page":"61","article-title":"H3F3A G34 mutation DNA sequencing and G34W immunohistochemistry analysis in 366 cases of giant cell tumors of bone and other bone tumors","volume":"36","author":"Gong","year":"2021","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.humpath.2026.106120_bib6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.humpath.2024.01.010","article-title":"Histones and their practical application in bone tumors: do I always need them?","volume":"147","author":"Reith","year":"2024","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2026.106120_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/his.13190","article-title":"H3F3A mutation in giant cell tumour of the bone is detected by immunohistochemistry using a monoclonal antibody against the G34W mutated site of the histone H3.3 variant","volume":"71","author":"L\u00fcke","year":"2017","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.humpath.2026.106120_bib8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/PAS.0000000000002387","article-title":"Malignant giant cell tumor of bone: a clinicopathologic series of 28 cases highlighting genetic differences compared with conventional, atypical, and metastasizing conventional tumors","volume":"49","author":"Papke","year":"2025","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.humpath.2026.106120_bib9","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/s41379-021-00972-x","article-title":"Histological and immunohistochemical features and genetic alterations in the malignant progression of giant cell tumor of bone: a possible association with TP53 mutation and loss of H3K27 trimethylation","volume":"35","author":"Ishihara","year":"2022","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.humpath.2026.106120_bib10","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/s41379-019-0318-5","article-title":"Absence of H3F3A mutation in a subset of malignant giant cell tumor of bone","volume":"32","author":"Yoshida","year":"2019","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2026.106120_bib11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/PAI.0000000000000964","article-title":"Reliability and role of mutation-specific H3F3A (Histone 3-3) G34W immunohistochemistry to differentiate giant cell tumor of bone from its clinicoradiologic and histologic mimics: an institutional study","volume":"30","author":"Pasricha","year":"2022","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"1","key":"10.1016\/j.humpath.2026.106120_bib12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/PAS.0000000000001555","article-title":"Immunohistochemical characterization of giant cell tumor of bone treated with denosumab: support for osteoblastic differentiation","volume":"45","author":"Kerr","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.humpath.2026.106120_bib13","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/his.14401","article-title":"H3F3A-mutated giant cell tumour of bone without giant cells-clinical presentation, radiology and histology of three cases","volume":"79","author":"Leinauer","year":"2021","journal-title":"Histopathology"},{"issue":"8","key":"10.1016\/j.humpath.2026.106120_bib14","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/PAS.0000000000000859","article-title":"H3F3A (Histone 3.3) G34W immunohistochemistry: a reliable marker defining benign and malignant giant cell tumor of bone","volume":"41","author":"Amary","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106120_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13569-017-0075-5","article-title":"Histone 3.3 hotspot mutations in conventional osteosarcomas: a comprehensive clinical and molecular characterization of six H3F3A mutated cases","volume":"7","author":"Koelsche","year":"2017","journal-title":"Clin Sarcoma Res"},{"issue":"7","key":"10.1016\/j.humpath.2026.106120_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2025.100763","article-title":"Methylation analysis reveals epigenetic congruence between bone sarcomas with H3-3A mutations and malignant giant cell tumors of bone","volume":"38","author":"Saoud","year":"2025","journal-title":"Mod Pathol"},{"issue":"10","key":"10.1016\/j.humpath.2026.106120_bib17","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/s41379-022-01102-x","article-title":"TransPORTEC consortium. p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial","volume":"35","author":"Vermij","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106120_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2025.100665","article-title":"Molecular pathological insights into tumorigenesis and progression of giant cell tumor of bone","volume":"51","author":"Yao","year":"2025","journal-title":"J Bone Oncol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726000894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726000894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T08:23:37Z","timestamp":1780043017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817726000894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":18,"alternative-id":["S0046817726000894"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106120","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteosarcomas with H3F3A mutation a clinicopathological and molecular genetic study of 7 cases with review of the literature","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106120","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106120"}}